Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
TSND.TO
HoldUnloved QualityTerrAscend Corp. · Healthcare · Canada · $243M · Avg Vol: $134K/d
60
StockRankGet insider-trade alerts
Q
53
V
62
M
39
P/E (TTM)
—
ROE
-27.0%
D/E
2.9x
Dividend %
—
Loading 1Y...
PRICE (1Y)+28.4%
SMA 50SMA 200
Close
$0.6866
RSI (14)
71.6
52W High
$1.45
From 52W High
0.5%
SCORE BREAKDOWN
Quality
53
ROIC
8.8%70.9
ROE
-27.0%28.7
GP/Assets
25.0%56.5
Op. Margin
18.0%81.4
FCF/Assets
3.5%63.3
Piotroski
377.2
Int. Cover
1.1x42.2
D/E Ratio
2.90x3.7
Current Ratio
1.83x34.4
Value
62
P/E (TTM)
—N/A
EV/EBITDA
5.9x87.7
P/FCF
12.6x74.8
P/B
1.9x63.0
P/S
1.0x83.8
Div Yield
—N/A
Momentum
39
52W High %
47%20.4
RS 6M
-14%44.3
SMA 50/200
0.91x36.3
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+105%75.1
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$243M
P/E (Forward)
137.8x
Gross Margin
52.8%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TSND.TO are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| TSND.TO | TerrAscend Corp.(you) | $243M | 60 | Hold |
| OGI | Organigram Global Inc. | $171M | 63 | Hold |
| ACB.TO | Aurora Cannabis Inc. | $253M | 40 | Hold |
| HLS.TO | HLS Therapeutics Inc. | $80M | 66 | Buy |
| CPH.TO | Cipher Pharmaceuticals Inc. | $265M | 92 | Strong Buy |
| CRDL.TO | Cardiol Therapeutics Inc. | $252M | 23 | Sell |
| GUD.TO | Knight Therapeutics Inc. | $682M | 76 | Buy |
| DB.V | Decibel Cannabis Company Inc. | $51M | 67 | Buy |
| XLY.TO | Auxly Cannabis Group Inc. | $232M | 98 | Strong Buy |
| CRON | Cronos Group Inc. | $1.2B | 68 | Buy |
Peer medians: ROE -37.9% · P/E 17.3x · Gross margin 44.2%